Parkwalk logo
  • Funds
  • Portfolio
  • News
  • Contact

Omega Diagnostics

Omega Diagnostics: ‘majority’ of CD4 manufacturing variants eliminated

 Category: Life Sciences

 Tags: AIM-listed, Life Sciences, Med-Tech, Omega Diagnostics, Syndicates

← Reinnervate
OxfordPV →

Terms of Use
Cookies
Twitter
Complaints Policy
Privacy Policy

no image

© Parkwalk 2025

Parkwalk is authorised and regulated by the Financial Conduct Authority